Levosulpiride

CAS No. 23672-07-3

Levosulpiride( (S)-(-)-Sulpiride | (S)(-)Sulpiride | (S) (-) Sulpiride )

Catalog No. M13682 CAS No. 23672-07-3

Levosulpiride is the (S)-enantiomer of sulpiride, which is a D2 receptor a antagonist, an atypical antipsychotic drug of the benzamide class.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
25MG 29 In Stock
50MG 34 In Stock
100MG 47 In Stock
200MG Get Quote In Stock
500MG 105 In Stock
1G 152 In Stock

Biological Information

  • Product Name
    Levosulpiride
  • Note
    Research use only, not for human use.
  • Brief Description
    Levosulpiride is the (S)-enantiomer of sulpiride, which is a D2 receptor a antagonist, an atypical antipsychotic drug of the benzamide class.
  • Description
    Levosulpiride is the (S)-enantiomer of sulpiride, which is a D2 receptor a antagonist, an atypical antipsychotic drug of the benzamide class.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (S)-(-)-Sulpiride | (S)(-)Sulpiride | (S) (-) Sulpiride
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Dopamine
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    23672-07-3
  • Formula Weight
    341.43
  • Molecular Formula
    C15H23N3O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 69 mg/mL (202.09 mM)
  • SMILES
    O=C(NC[C@H]1N(CC)CCC1)C2=CC(S(=O)(N)=O)=CC=C2OC
  • Chemical Name
    (S)-(-)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Saporito F, et al. Int J Cardiol. 2014 Aug 1;175(2):383-4.
molnova catalog
related products
  • Sertindole

    Sertindole is an atypical antipsychotic that binds to dopamine D2 receptors and the serotonin (5-HT) receptor subtypes 5-HT1D 5-HT2A and 5-HT2C (Kds = 2.7 20 0.14 and 6 nM respectively).

  • PF-00217830

    PF-00217830 is a serotonin 1A receptor agonist, dopamine D2 receptor agonist, and serotonin 2A receptor antagonist.PF-00217830 may be used in the study of schizophrenia.

  • UCM-1306

    UCM-1306 is a potent and orally active allosteric modulator (PAM) of the human dopamine D1 receptor. It increases the maximal effect of endogenous dopamine (DA) in both human and mouse D1 receptors.